Skip to main content

Epidemiological profile of meningitis in Iran before pentavalent vaccine introduction



No reliable and comprehensive study has been published on the incidence and epidemiological profile of meningitis in Iran from 2008 to 2014, before pneumococcal conjugate vaccine (PCV) and pentavalent vaccine (DTPw-Hep B-Hib (PRP-T) vaccine (pentavac) (adsorbed)) introduction. The present study aimed to portray the epidemiological profile of meningitis in Iran from 2008 to 2014.


Data on meningitis cases aged from 1 day to 110 years were extracted from national notifiable diseases surveillance system from March 2008 to December 2014 in Iran. A total number of 48,006 cases of suspected meningitis were identified and 1468 cases of which met the criteria for diagnosis-confirmed meningitis. Of 1468 cases, 1352 patients were included in the study.


The great number of cases reported from urban areas. Moreover, males were more predominant than females (58.51% vs. 33.81%) in total. The estimated annual incidence rate of meningitis varied from 0.28/100000 in 2008 to 0.09/100000 in 2014. Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis were the most leading pathogens causing bacterial meningitis, accounted for 266(23.44%), 145(12.78%), 95(8.37%) of cases, respectively. Each of the three bacterial species showed a descending trend. The majority of infected subjects are children under five years.


Unlike the decreasing trend of meningitis and high percentage of cultures with negative results, according to World Health Organization recommendation PCV introduction into routine immunization is evident. Implementing an enhanced surveillance system to provide high quality data on epidemiological profile of meningitis in Iran is necessary.

Peer Review reports


Meningitis is defined as an inflammation of the meninges, the protective covering that surrounds the brain and spinal cord, mostly caused by bacterial, viral and fungal infection. Moreover, meningitis can be triggered by chemical irritation, subarachnoid hemorrhage, cancer and other conditions [1]. However, aseptic meningitis is more frequent compared to bacterial meningitis with a non-malignant clinical course [2]. The results of the studies done so far show that bacterial meningitis is a serious threat to global health in that there are 1.2 million cases of bacterial meningitis all over the world, accounting for almost 171,000 deaths annually [3, 4]. Although the incidence of meningitis is reported to be high among infants and children, it may be observed among healthy older children and adolescent. Despite the continuous advances in the development of more effective antibacterial medications every year, bacterial meningitis has a high fatality rate of 2 to 30% [5, 6]. Moreover, the neurological sequelae arise in about 30% of the survivors [7]. Ninety eight percent of 5.6 million disability-adjusted life years (DALYs) attributed to meningitis occur in countries with a low or middle income. In high-income countries, bacterial meningitis is among the top ten causes of death in children under the age of 14 [8]. Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis the most leading organisms causing bacterial meningitis universally,are responsible for 90% of reported cases in childhood [9]. Subsequent to the development of highly effective conjugated vaccines to prevent meningitis universally, major variations in the epidemiological profile of meningitis are expected. Hence, the monitoring of disease trend in pre and post-vaccination era and the scrutiny of its epidemiological characteristics particularly those of bacterial meningitis seem necessary.

Meningitis is reported as a national notifiable diseases surveillance system in Iran. Such a system can provide detailed information concerning the geographical distribution of diseases, age and sex, groups at risk, the disease trend and the possible occurrence of epidemics. The information can be provided with the result that necessary preventive steps could be taken through designing and conducting research studies. These are to help specialists to design health interventions, and to evaluate effectiveness of implemented health interventions. Since national notifiable diseases surveillance system of meningitis has applied a passive approach. So, it is most likely to be underestimated the incidence of meningitis. Moreover pentavalent vaccine (DTPw-Hep B-Hib (PRP-T) vaccine (pentavac) (adsorbed)) was introduced in Iran in November 2014.

So far, there have been no reports regarding the incidence of meningitis in Iran, and the majority of the published studies associated with meningitis have been carried out on single etiological agent and certain geographical areas. Hence, the present study, using surveillance data aimed to portray the epidemiologic profile of meningitis in the country over a period of 7 years (from 2008 to 2014). It is expected that after the necessary precise information is gathered through evaluating the current situation in the country, significant steps can be taken towards making evidence-based decisions in order to manage and organize patients with meningitis so that the disease can be controlled and prevented.


Data were extracted from the national notifiable diseases surveillance system from March 2008 to December 2014. The Center for Communicable Diseases Control in Iran has implemented a national surveillance system for meningitis. The current surveillance system in the country is a population-based surveillance therefore, all hospital of medical sciences are required to report all meningitis cases using passive approach [10,11,12,13]. In order to achieve the study objectives, the general information related to demographic variable (age, sex and location), para-clinical results, final diagnosis, outcome of patients, and vaccination status of patients were extracted using the standardized case report form.

In our set-up, we classified the patients into three case types (suspected, probable and confirmed cases). The following clinical and laboratory criteria were used as a basis for the definition of case types and the subsequent classification of the patients into 3 different groups and viral meningitis [14].:


Anyone at any age with a sudden onset of fever (38.5 °C rectal or 38 °C axillary) and at least one of the following signs observed

  • Neck stiffness

  • Bulging fontanel (for infant)

  • Altered consciousness or other meningeal sign (including headache, vomiting and any type of sudden neurologic sequelae.


A suspected case whose cerebrospinal fluid (CSF) examination shows at least one of the followings

  • Turbid or purulent appearance

  • Neutrophilic pleocytosis in CSF (≥100 white blood cells/mm3)

  • Pleocytosis (10–100 white blood cells/mm3) along with increased protein (> 100 mg/dl) or hypoglycorrhachia

  • A Gram stain results showing one of these findings

    -Gram negative coccobacilli (suggesting Haemophilus influenzae)

    -Gram positive diplococci (suggesting Streptococcus pneumoniae)

    -Gram negative diplococcic (suggesting Neisseria meningitidis)


A suspected or probable cases with one of the followings

  • Positive culture of CSF or blood with identification Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis (gold standard for confirmed diagnosis) or

  • Positive CSF antigen detection for Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis by latex agglutination test (LAT) if available

Aseptic meningitis was defined as follows:

All of suspected cases of meningitis with negative/normal CSF, based on age, clinical symptoms of patients and cytological and biochemical parameters are considered as aseptic meningitis.

  • Suspected viral meningitis: cases of fever (more than 38.5 degrees) and neck stiffness with changes in consciousness or prominent tangents and fontanels in infants and children.

  • Probable Viral Meningitis: A suspected case with at least one of the following:

    -Normal glucose in the cerebrospinal fluid and a mild or normal increase in cerebrospinal fluid protein (< 50 mg / dl), a moderate increase in cerebrospinal fluid (< 500 cells / mm) and lymphocyte excretion (<% 50).

    -Epidemiological link with a definite case or existing epidemic

  • Confirmed viral meningitis: a suspected or probable case with laboratory confirmation or negative culture of cerebrospinal fluid.

Finally, data were analyzed by Stata software, version 11 (Stata Corp, College Station, TX, USA) using descriptive statistics (frequency, mean, standard deviation). To investigate the association between qualitative variables the chi-squared test was used.

Incidence rate of meningitis of all types for each year of the study period was calculated by dividing the number of cases observed in each year by the average population of the country in the same year. For this purpose, the available data concerning the population of the country were obtained from the official website of the Statistical Center of Iran. In addition, the monthly trend of meningitis cases and the frequency distribution of bacterial meningitis cases according to pathogenic agent were plotted on line graphs. All statistical analysis were performed at a confidence interval (CI) of 95%.


During the study 48,006 patients (age ranging from 1 day to 110 years) with clinical sign and symptoms of meningitis were included in the study. Of the total 48,006 cases identified in this study, 9853 cases were categorized as probable while 1468 ones as confirmed meningitis, 116 cases of whom were excluded because of missing data. Of 1352 cases, bacterial meningitis was more prevalent as 1135 (77.31%) of cases is accounted for, followed by 217 (14.78%) of cases as aspetic meningitis. The percentage of male cases were 58.51, the percentage of female cases were 33.51. The sex distribution suggested that the incidence of bacterial meningitis in men is higher than women. A similar result was also reported for aseptic meningitis although it was not statistically significant (p = 0.232). In addition, the results of the statistical analyses showed that approximately 73% of patients with both aseptic and bacterial meningitis were resident in urban areas (p = 0.354). The present study demonstrated that the frequency of aseptic meningitis is more common in age group of under 5 years (62.21%) as 38% of which were seen in children under 1 year and 49.42% of bacterial origin were observed among children under 5 years (p < 0.001). Streptococcus pneumoniae was the prevailing microorganism that found in 266 (23.44%) cases [Table 1].

Table 1 The epidemiological and laboratory characteristics of patients with meningitis

The incidence of meningitis due to Streptococcus pneumoniae declined during the study period, as its frequency differed from 41 cases in 2008 to 15 cases in 2014. Moreover, Haemophilus influenzae type b and Neisseria meningitidis also were found to account for 145 (12.78%), 95 (8.37%) cases respectively (p < 0.001). Although, both had a declining trend [Fig. 1]. It should be mentioned that in 629 cases (55.43%) of presumable bacterial meningitis cases in our study, no microorganism was detected. The case-fatality rate (CFR) of bacterial meningitis was 8.55%, with Neisseria meningitidis having the highest CFR (18.95%), followed by Streptococcus pneumoniae with a CFR of 8.65% while this rate was relatively low for aseptic meningitis (1.84%). In addition, CSF appearance in bacterial meningitis was turbid in 45.73% of cases, clear in 38.85%, bloody in 3.7% and unknown in 4.41%. However, 58.06% of the CSF sample in patients with aspetic meningitis was clear. A comprehensive description of cerebrospinal fluid analysis of patients is provided in [Table 2]. Top three common drug regime for Meningitis cases during study period were ceftriaxone plus vancomycin (46.5%), ceftriaxone (9.4%) and vancomycin (7%).

Fig. 1

Distribution of bacterial meningitis cases by aetiological agents in Iran, (2008–2014)

Table 2 Cytological parameters in different type of meningitis in Iran during 2008–2014

More specifically, at the beginning of the study period, during the years between 2008 and 2010, the annual incidence of meningitis of all types had a rising trend (0.28–0.34/100000 population). However, this upward trend ended in the following years until, with some slight fluctuations, it hit a minimum of 0.09 per 100,000 people in 2014 [Table 3].

Table 3 Incidence rates of meningitis based on case definition (per 100,000 populations)

As for seasonality, as shown in Fig. 2, the results of the present study revealed that the monthly incidence of meningitis showed a wide fluctuation between 47 cases in October 2010 and 3 cases in March 2008. Moreover, the majority of the meningitis cases were reported in cold months from fall to spring [Fig. 2].

Fig. 2

Time trend of monthly counts of meningitis in Iran from March 2008 to December 2014


Considering the population of Iran in the years under study (March 2008 to December 2014), the estimated annual incidence of meningitis varied from 0.28/100000 population in 2008 to 0.09/100000 population in 2014. However, the published reports showed that meningitis incidence rate in USA was 1.1 cases per 100,000 population [15]. Moreover, the finding of similar studies conducted in several European countries revealed that the incidence rate of bacterial meningitis was 2.6/100000 population in Netherlands, 3.7/100000 population in Italy, 4.3/100000 population in Kozovo and 3.2/100000 population in Iceland [16,17,18,19]. In other studies conducted in neighboring countries in the Middle East such as Egypt, Oman and United Arab Emirates, the incidence rate for the meningitis was reported to be 3.65/100000, 3/100000, 1/100000 population, respectively [20,21,22]. These significant differences in the meningitis incidence rate observed are probably due to different geographical conditions of these countries, immunization status, age groups, time of the study and type of surveillance system prevailing in the countries for the detection of meningitis cases.

Based on the results obtained in the present study, the incidence of meningitis had a downward trend over the years under study. With the same token, the number of cases affected with meningeal pathogen also dropped, a phenomenon which is unrelated to vaccination. In view of the fact that there is currently no countrywide extensive immunization program against the major meningeal pathogen in Iran, with the exclusion of the Hib vaccine which was added into the routine immunization schedule in December of 2014. It must be emphasized that the present study was under way during the year when Hib vaccine was implemented in Iran, the subjects of this study did not receive any vaccines. Therefore, the observed reduction in the incidence rate of meningitis can be accounted for by several other factors including, improved life standards, easier and better access to health care facilities, extensive health education provided for the public, effective preventive and controlling measures taken. However, this observed reduction in incidence rate of meningitis in the country may have been quite artificial, accounted for by the weak surveillance of meningitis, the lack of sufficient attention to surveillance programs of meningitis by the health ministry, high turnover of the personnel unaware of surveillance system, the absence of appropriate infrastructure for the clinical diagnosis of the disease, the lack of transparent rules and regulations for the timely and reliable reporting of cases, a limited laboratory capacity in most regions of the country for definitive diagnosis of early cases with little sophisticated laboratory facilities for isolation pathogens. Contrary to the above observation, the emergence and development of the effective preventive interventions (such as Hib, pneumococcal conjugate vaccines) have dramatically altered the epidemiology of bacterial meningitis in countries where vaccination against the meningeal pathogens is routine. These vaccines not only have significantly reduced the incidence of meningitis caused by these pathogens but also have shifted the median age of the occurrence of bacterial meningitis from infancy to adulthood [23,24,25,26].

As mentioned previously, Streptococcus pneumoniae, Haemophilus influenzae type b, Neisseria meningitidis are the main triad agents causing bacterial meningitis. Moreover, the most predominant age group unprotected against meningitis is children under the age of 5. Our finding is affirmed by the results of the published works in various geographic regions of Iran [27,28,29]. However, an observational study in England and Wales noted that Neisseria meningitidis was a leading pathogen of bacterial meningitis, followed by Streptococcus pneumoniae [30]. On the other hand despite the implementation of immunization program against Haemophilus influenzae type b, this organism is still the major cause of bacterial meningitis among young children in Tanzania [31], a finding which is in line with the results obtained in Nepal [32]. Streptococcus pneumoniae persists as the foremost organism of bacterial meningitis in the USA. Over the 14 year period (from 1997 to 2010), the remarkable lessening in the incidence rate of meningococcal and H influenza meningitis was observed which is primarily affiliated with the inclusion of conjugated vaccines. At the moment both pathogens have a lower prevalence and have been supplanted by other two common pathogens, that is, Staphylococcus species and Gram-negative bacteria [33]. The spectrum of meningitis pathogens is diverse around the world. It can be caused by one reason or another including, geographical differences, age group, immune function, vaccination coverage, effectiveness of existing vaccines and different immunization situation versus pathogens causing disease.

In this study high rate of meningitis cases presumed to be bacterial without identifying the causative organism. Seventy (4.7%) cases of meningitis with undetermined etiology could be attributable to several factors such as limited facilities of bacteriological culture, the generally low sensitivity of conventional laboratory methods, the lack of the necessary skill and experience of observer for the detection and isolation of pathogens, the failure to give a timely report about disease cases, the use of antibiotic prior to lumbar puncture (LP), all of which can adversely affect the quality of surveillance data. Unfortunately no information concerning the causes of aseptic meningitis is at hand.

Cerebrospinal fluid (CSF) was positive in only 10% of patients, which is consistent with the results of other studies in Iran [34, 35]. However, according to reports published in other countries, CSF culture has been positive in more than 70% cases [36, 37]. The main reasons for such significant difference can be due to the improper use of antibiotic prior to culture, the failure to comply with technical guidelines in storing and transporting samples to the laboratory, incorrect sampling methods and insufficiency of microbiological culturing [38]. In our study approximately 40% of the patients were pre-treated with antibiotics before LP, which can influence test result, leading to negative cerebrospinal fluid culture. Under such circumstances, the use of more advanced method such as antigen detection and PCR seems advisable and useful.

Male ascendancy in meningitis was discovered in the present study which is in keeping with the other ones. It can be attributable to biological or social factors [39, 40].

In the present study, the CSF analysis demonstrated that the median value of leukocytes count in patients with bacterial meningitis was 4325 cell/mm3, with polymorphonuclear (PMN) predominance which is persistent with previous studies [41, 42]. However, this value was reported 663 cell/mm with lymphocytes dominance in aseptic meningitis including viral cases. Considering the fact that a cell count lower than 100 is more prevalent in viral meningitis [43], our result are in conflict with those found by Wang et al. [44]. This inflated rise can be due to peripheral blood in CSF sample following LP and LP technique [43].

In this study, the median of CSF glucose concentration was reported 49.39 mg/dl in bacterial meningitis, which is different than results of other studies [45]. The CSF glucose level is used as a basis to distinguish bacterial meningitis (in which it usually decreased, usually < 40 mg/dl) from viral meningitis (in which the glucose levels are usually unaltered). Generally, A CSF: blood glucose ratio of less than 0.4 shows hypoglycorrhachia [46]. However, in our survey, the median CSF glucose in patients was higher than 40 mg/dl. This observed increase may have been caused by the administration of antibiotics before hospitalization, and the LP performance. Under such conditions, bacteria can be killed and consequently, the consumption of glucose reduces [47]. As CSF glucose is about two third of the serum glucose, an increase in the level of serum glucose can trigger an increase in of CSF glucose level [43]. CSF Glucose level is normal in viral meningitis. Another diagnostic indicator for distinguishing bacterial from viral meningitis is CSF protein values. In this study, the median value of protein was higher in bacterial meningitis than viral meningitis, which is similar to those of other studies [48, 49].

A retrospective design contingent upon surveillance data is imperfect, inaccurate and less important compared to the one which uses prospective data. However, it should be kept in mind that such data are not currently accessible.

In this study, the estimated incidence rate of meningitis during the time-span under study did not reflect the actual burden of meningitis in Iran primarily because the analyses were conducted only on laboratory-tested cases of meningitis (culture positive). Due to the unavailability of more advanced diagnostic evaluations (such as PCR), the identification of culture-negative cases in the laboratory across the country is not possible; the present study did not contain such data. Underestimation of incidence of meningitis because of passive approach of national notifiable diseases surveillance system of meningitis in Iran and lack of appropriate data on serotype distribution of meningitis cases are other limitation of this work.

Moreover, the currently operating surveillance does not provide the comprehensive information concerning some epidemiologic features of meningitis for reported cases, serotype distribution and replacement in this study as highlighted by published literature [50, 51]. Nor were there information on causative agents for viral meningitis, serotypes distribution of bacterial meningitis agents, antimicrobial resistance and clinical outcome of patients. Even information published on a series of meningitis variables is not completely represented. Finally, high rate of cases with undetermined pathogens is another major shortcoming of our study.

Despite the limitations mentioned, the present study is the first in its type in that the analyses were conducted on a representative collection of patients with meningitis from all over the country. Therefore, the findings obtained enjoy a good generalizability characteristic; with direct implications for of study results and the obtained output from this survey can be helpful in identifying the main priorities for development of efficient control and prevention programs of meningitis. In addition, the results of this study can be used to revising the surveillance system of meningitis, monitoring the trend of invasive pneumococcal disease and decision to PCV introduction.


Unlike previous studies, the findings of the present study showed that bacterial meningitis was more common than aseptic meningitis. Rate of culture positivity was very low. Similar to studies in other countries, the incidence rate of meningitis decreased during the study period in Iran, with no convincing and plausible explanation specified for the observed reduction in incidence rate. Nonetheless, it should be noted that reported confirmed cases of meningitis by national notifiable diseases surveillance system of meningitis has limited to January, February and March 2014. This may leaded to observe such decline in the incidence rate of meningitis during 2014 in comparison to previous years of study period.

Streptococcus pneumoniae, Haemophilus influenzae type b and Neisseria meningitidis were the three most prevailing causes of bacterial meningitis which affects more children under the age of 5. Some indicators derived from the CSF analysis such as PMN percentage, the CSF glucose and protein values were used as bases for the differentiation of aseptic from bacterial meningitis. The findings of this study emphasize the need for more efficient surveillance and control of meningitis in Iran under the light of following recommendations:

  • Continuous monitoring the national notifiable diseases surveillance system of and implementing an enhanced surveillance system

  • Establishment of the strict and precise rules and regulation for the timely reporting of cases

  • Applying experienced and well-trained human resources and making optimal use of available human resources

  • Enhancing and empowering laboratory capacity throughout the country for definitive diagnosis of cases along with sophisticated laboratory facilities.

Availability of data and materials

The dataset of the current study is available from the corresponding author at a reasonable request.



Case fatality rate


Cerebrospinal fluid


Disability-adjusted life year


Pneumococcal conjugate vaccine


  1. 1.

    World Health Organization. Meningococcal disease [].

  2. 2.

    Putz K, Hayani K, Zar FA. Meningitis. Prim Care Clin Office Pract. 2013;40(3):707–26.

    Article  Google Scholar 

  3. 3.

    Scheld WM, Koedel U, Nathan B, Pfister H-W: Pathophysiology of bacterial meningitis: mechanism (s) of neuronal injury. Journal of Infectious Diseases 2002, 186(Supplement 2):S225-S233.

  4. 4.

    Tzanakaki G, Mastrantonio P. Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region. Int J Antimicrob Agents. 2007;29(6):621–9.

    Article  CAS  Google Scholar 

  5. 5.

    Feigin R, Curter W: Bacterial meningitis beyond the neonatal period. In: Feigin & Cherry’s Textbook of Pediatric Infectious Diseases edn. edn. Edited by Feigin R, Cherry J, Harrison R, Kaplan S; 2009.

  6. 6.

    Sáez-Llorens X, McCracken GH. Bacterial meningitis in children. Lancet. 2003;361(9375):2139–48.

    Article  Google Scholar 

  7. 7.

    Neuman HB, Wald ER. Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh: 1988-1998. Clin Pediatr. 2001;40(11):595–600.

    Article  CAS  Google Scholar 

  8. 8.

    Mathers C. The global burden of disease: 2004 update: World Health Organization; 2008.

    Google Scholar 

  9. 9.

    Tzanakaki G, Tsopanomichalou M, Kesanopoulos K, Matzourani R, Sioumala M. Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae. Clin Microbiol Infect. 2005;11(5):386–90.

    Article  CAS  Google Scholar 

  10. 10.

    Faryadres M, Karami M, Moghimbeigi A, Esmailnasab N, Pazhouhi K. Levels of alarm thresholds of meningitis outbreaks in Hamadan Province, west of Iran. Journal of research in health sciences. 2015;15(1):62–5.

    PubMed  PubMed Central  Google Scholar 

  11. 11.

    Karami M, Soori H, Mehrabi Y, Haghdoost AA, Gouya MM. Real time detection of a measles outbreak using the exponentially weighted moving average: does it work? Journal of research in health sciences. 2012;12(1):25–30.

    PubMed  PubMed Central  Google Scholar 

  12. 12.

    Pazhouhi K, Karami M, Esmailnasab N, Moghim Biygi A, Fariadras M. Seasonal trends and explainable patterns of meningitis: data preprocessing on fever and neurological symptoms syndrome. Razi Journal of Medical Sciences. 2015;21(128):18–27.

    Google Scholar 

  13. 13.

    Pazhouhi H, Karami M, Esmailnasab N, Moghimbeigi A, Fariadras M: Temporal Patterns of Meningitis in Hamadan, Western Iran: Addressing and Removing Explainable Patterns. Archives of Clinical Infectious Diseases 2016, 11(3).

  14. 14.

    Esteghamati A, Asgari F, Godarzi N. Guideline of meningitis surveillance. 2nd ed. Center of disease control: Tehran; 2005.

    Google Scholar 

  15. 15.

    Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Giorgi Rossi P, Mantovani J, Ferroni E, Forcina A, Stanghellini E, Curtale F, Borgia P: Incidence of bacterial meningitis (2001-2005) in Lazio, Italy: the results of a integrated surveillance system BMC infectious diseases 2009, 9:13.

  17. 17.

    Namani SA, Koci RA, Qehaja-Bucaj E, Ajazaj-Berisha L, Mehmeti M. The epidemiology of bacterial meningitis in Kosovo. Journal of infection in developing countries. 2014;8(7):823–30.

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Thornorethardottir A, Erlendsdottir H, Sigurethardottir B, Harethardottir H, Reynisson IK, Gottfreethsson M, Guethmundsson S. Bacterial meningitis in adults in Iceland, 1995-2010. Scand J Infect Dis. 2014;46(5):354–60.

    Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849–59.

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Dash N, Al Khusaiby S, Behlim T, Mohammadi A, Mohammadi E, Al Awaidy S: Epidemiology of meningitis in Oman, 2000-2005. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 2009, 15(6):1358–1364.

  21. 21.

    Dash N, Ameen AS, Sheek-Hussein MM, Smego RA Jr. Epidemiology of meningitis in Al-Ain, United Arab Emirates, 2000-2005. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2007;11(4):309–12.

    Article  Google Scholar 

  22. 22.

    Mobarak EI. Trend, features and outcome of meningitis in the communicable diseases hospital, Alexandria, Egypt, 1997-2006. The Journal of the Egyptian Public Health Association. 2012;87(1–2):16–23.

    Article  Google Scholar 

  23. 23.

    Azevedo LC, Toscano CM, Bierrenbach AL. Bacterial meningitis in Brazil: baseline epidemiologic assessment of the decade prior to the introduction of pneumococcal and meningococcal vaccines. PLoS One. 2013;8(6):e64524.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Georges S, Lepoutre A, Dabernat H, Levy-Bruhl D. Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction. Epidemiol Infect. 2013;141(9):1787–96.

    Article  CAS  Google Scholar 

  25. 25.

    Shinjoh M, Iwata S, Yagihashi T, Sato Y, Akita H, Takahashi T, Sunakawa K. Recent trends in pediatric bacterial meningitis in Japan--a country where Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines have just been introduced. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2014;20(8):477–83.

    Article  Google Scholar 

  26. 26.

    Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, Harrison LH, Farley MM, Reingold A, Bennett NM, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Abdinia B, Ahangarzadeh Rezaee M, Abdoli Oskouie S. Etiology and antimicrobial resistance patterns of acute bacterial meningitis in children: a 10-year referral hospital-based study in Northwest Iran. Iran Red Crescent Med J. 2014;16(7):e17616.

    Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Mahmoudi S, Zandi H, Pourakbari B, Ashtiani MT, Mamishi S. Acute bacterial meningitis among children admitted into an Iranian referral children's hospital. Jpn J Infect Dis. 2013;66(6):503–6.

    Article  Google Scholar 

  29. 29.

    Sasan MS, Alborzi A, Ziyaeyan M. Epidemiology of aseptic meningitis in infants and children (shiraz - Iran). Arch Clin Infect Dis. 2012;7(4):116–8.

    Article  Google Scholar 

  30. 30.

    Okike IO, Ribeiro S, Ramsay ME, Heath PT, Sharland M, Ladhani SN. Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. Lancet Infect Dis. 2014;14(4):301–7.

    Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Storz C, Schutz C, Tluway A, Matuja W, Schmutzhard E, Winkler AS. Clinical findings and management of patients with meningitis with an emphasis on Haemophilus influenzae meningitis in rural Tanzania. J Neurol Sci. 2016;366:52–8.

    Article  Google Scholar 

  32. 32.

    Shrestha RG, Tandukar S, Ansari S, Subedi A, Shrestha A, Poudel R, Adhikari N, Basnyat SR, Sherchand JB. Bacterial meningitis in children under 15 years of age in Nepal. BMC Pediatr. 2015;15:94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis. 2014;14(9):813–9.

    Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Amini M, Bahador M, Bahador M. Common cause and cerebrospinal fluid changes of acute bacterial meningitis. Iran J Pathol. 2009;4(2):75–9.

    Google Scholar 

  35. 35.

    Kanani S, Moradi G. Epidemiological survey of acute meningitis in Kurdistan province from 1381 to the end of 1383; 2005.

    Google Scholar 

  36. 36.

    Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults. Brain. 2003;126(5):1015–25.

    Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Theodoridou MN, Vasilopoulou VA, Atsali EE, Pangalis AM, Mostrou GJ, Syriopoulou VP, Hadjichristodoulou CS. Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period. BMC Infect Dis. 2007;7(1):101.

    Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Heydari B, Khalili H, Karimzadeh I, Emadi-Koochak H: Clinical, Paraclinical, and antimicrobial resistance features of community-acquired acute bacterial meningitis at a large infectious diseases Ward in Tehran, Iran Iranian Journal of Pharmaceutical Research 2016, 15(1):347–354.

  39. 39.

    Ghuneim N, Dheir M, AbuAli K: Epidemiology of Different Types of Meningitis Cases in Gaza Governorates,Occupied Palestinian Territory, December 2013–January 2014. J Antivir Antiretrovir 2016, 8(1):26–34.

  40. 40.

    Pérez AE, Dickinson FO, Rodríguez M. Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infect Dis. 2010;10(1):1.

    Article  Google Scholar 

  41. 41.

    Abro AH, Abdou AS, Ali H, Ustadi AM, Hasab AAH. Cerebrospinal fluid analysis acute bacterial versus viral meningitis. Pak J Med Sci. 2008;24(5):645–50.

    Google Scholar 

  42. 42.

    Tamune H, Takeya H, Suzuki W, Tagashira Y, Kuki T, Honda H, Nakamura M. Cerebrospinal fluid/blood glucose ratio as an indicator for bacterial meningitis. Am J Emerg Med. 2014;32(3):263–6.

    Article  Google Scholar 

  43. 43.

    Seehusen DA, Reeves MM, Fomin D. Cerebrospinal fluid analysis. Am Fam Physician. 2003;68(6):1103–8.

    PubMed  Google Scholar 

  44. 44.

    Wang Y, Chiua N, Ho C, Chia H. Comparison of childhood aseptic meningitis with bacterial meningitis in a tertiary Children’s Hospital of Taiwan. J Meningitis. 2016;1(103):2.

    Google Scholar 

  45. 45.

    Pandey P, Jha B, Shrestha A. Cytological and biochemical profile of cerebrospinal fluid from meningitis patients. Annals of Clinical Chemistry and Laboratory Medicine. 2015;1(1):2–5.

    Article  Google Scholar 

  46. 46.

    Venkatesh B, Scott P, Ziegenfuss M. Cerebrospinal fluid in critical illness; 2000.

    Google Scholar 

  47. 47.

    Ghaemi E, Mohammadian S, Abdulmohammadi L, Mansourian AR, BehnamPour N. R T: Paraclinical and clinical findings in100 patients with suspected meningitis. Journal of Gorgan Universityof Medical Sciences. 2001;3(7):17–23.

    Google Scholar 

  48. 48.

    Águeda S, Campos T, Maia A. Prediction of bacterial meningitis based on cerebrospinal fluid pleocytosis in children. Braz J Infect Dis. 2013;17(4):401–4.

    Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Gowin E, Wysocki J, Avonts D, Januszkiewicz-Lewandowska D, Michalak M. Usefulness of inflammatory biomarkers in discriminating between bacterial and aseptic meningitis in hospitalized children from a population with low vaccination coverage. Archives of medical science: AMS. 2016;12(2):408–14.

    Article  PubMed  PubMed Central  Google Scholar 

  50. 50.

    Karami M, Berangi Z, Mohammadi Y, Zahraei SM. Nasopharyngeal pneumococcal colonization among children after pneumococcal conjugate vaccine introduction. Int J Pediatr. 2017;5(8):5547–8.

    Google Scholar 

  51. 51.

    Zhou JY, Isaacson-Schmid M, Utterson EC, Todd EM, McFarland M, Sivapalan J, Niehoff JM, Burnham CD, Morley SC. Prevalence of nasopharyngeal pneumococcal colonization in children and antimicrobial susceptibility profiles of carriage isolates. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2015;39:50–2.

    Article  Google Scholar 

Download references


This study has been adapted from an MSc thesis at Hamadan University of Medical Sciences.

Authors would like to thank all contributors of the Iranian National Surveillance System especially Dr. Gouya and Ms. Sabouri for providing data.


The study was partially funded by Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences (No. 9411136359). Funding body of this study did not play any role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Author information




All authors have approved the manuscript. MK has established first idea data analysis and drafted manuscript, ZB, SMZ, HJ and SH helped to design and conduct the study. MK, ZB, SMZ, HJ, SH, MN and YM have had substantial contribution in data gathering, manuscript drafting, and critical revision of manuscript and data analysis. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Manoochehr Karami.

Ethics declarations

Ethics approval and consent to participate

The study was provided ethical approval by the Hamadan University of Medical Sciences IR.UMSHA.REC (Grant No: 9411136359).

Consent for publication

Not applicable.

Competing interests

The authors declares that they have no competing interests

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

ZB and MK are Multiple first authors (Co-first authors)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Berangi, Z., Karami, M., Mohammadi, Y. et al. Epidemiological profile of meningitis in Iran before pentavalent vaccine introduction. BMC Pediatr 19, 370 (2019).

Download citation


  • Public health surveillance
  • Meningitis
  • Iran
  • Streptococcus pneumoniae
  • Neisseria meningitidis
  • Haemophilus influenzae